RIGL

47.11

0.21% -0.10

Handel nachbörslich: 46.77 -0.34 -0.72%

Rigel Pharmaceuticals (RIGL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$47.21

Offen:

$47.13

24-Stunden-Volumen:

312.22K

Relative Volume:

0.50

Marktkapitalisierung:

$855.11M

Einnahmen:

$116.88M

Nettoeinkommen (Verlust:

$-25.09M

KGV:

-336.50

EPS:

-0.14

Netto-Cashflow:

$-20.74M

1W Leistung:

-7.55%

1M Leistung:

+66.00%

6M Leistung:

+129.36%

1J Leistung:

+77.84%

1-Tages-Spanne:

$46.76

$48.50

1-Wochen-Bereich:

$43.81

$52.24

52-Wochen-Spanne:

$14.63

$52.24

Rigel Pharmaceuticals Stock (RIGL) Company Profile

Firmenname

Rigel Pharmaceuticals

Sektor

Healthcare (1131)

Branche

Biotechnology (632)

Telefon

650-624-1100

Adresse

611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA

Mitarbeiter

164

Twitter

@rigelpharma

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

RIGL's Discussions on Twitter

Vergleichen Sie RIGL mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
RIGL Rigel Pharmaceuticals	47.11	856.92M	116.88M	-25.09M	-20.74M	-0.14
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Rigel Pharmaceuticals Stock (RIGL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-05	Hochstufung	Jefferies	Hold → Buy
2023-04-03	Fortgesetzt	Piper Sandler	Neutral
2022-06-09	Herabstufung	Citigroup	Buy → Neutral
2022-06-08	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2022-06-08	Herabstufung	Piper Sandler	Overweight → Neutral
2022-03-23	Eingeleitet	B. Riley Securities	Neutral
2020-11-09	Herabstufung	JP Morgan	Overweight → Neutral
2019-11-15	Fortgesetzt	Cantor Fitzgerald	Overweight
2019-09-26	Fortgesetzt	JP Morgan	Overweight
2019-03-01	Bestätigt	Cantor Fitzgerald	Overweight
2018-08-27	Eingeleitet	Citigroup	Buy
2018-05-02	Bestätigt	Cantor Fitzgerald	Overweight
2017-12-21	Fortgesetzt	Piper Jaffray	Overweight
2017-12-15	Eingeleitet	Cantor Fitzgerald	Overweight
2017-11-06	Fortgesetzt	H.C. Wainwright	Buy
2017-03-09	Bestätigt	H.C. Wainwright	Buy
2016-08-31	Bestätigt	H.C. Wainwright	Buy
2016-08-30	Bestätigt	Piper Jaffray	Overweight
2016-07-13	Eingeleitet	H.C. Wainwright	Buy
2016-06-13	Eingeleitet	Piper Jaffray	Overweight
2016-04-22	Hochstufung	JP Morgan	Neutral → Overweight
2013-04-08	Bestätigt	Stifel	Buy
2012-11-29	Eingeleitet	UBS	Neutral
2012-11-06	Bestätigt	Oppenheimer	Outperform
2012-03-26	Eingeleitet	Canaccord Genuity	Hold
2010-12-10	Herabstufung	MP Advisors	Outperform → Market Perform

Alle ansehen

Rigel Pharmaceuticals Aktie (RIGL) Neueste Nachrichten

01:51 AM

Why pension funds invest in Rigel Pharmaceuticals Inc. (RI2) stock2025 Year in Review & Verified Stock Trade Ideas - Newser

01:51 AM

01:43 AM

Will Rigel Pharmaceuticals Inc. (RI2) stock enhance shareholder valueMarket Sentiment Report & AI Based Trade Execution Alerts - Newser

01:43 AM

04:40 AM

Is Rigel Pharmaceuticals Inc. (RI2) stock supported by free cash flowWeekly Investment Recap & AI Optimized Trading Strategy Guides - Newser

04:40 AM

Dec 03, 2025

Should Value Investors Buy Rigel Pharmaceuticals (RIGL) Stock? - Yahoo Finance

Dec 03, 2025

Why Rigel Pharmaceuticals Inc. (RI2) stock could break out in 2025 - Newser

Dec 03, 2025

Will Rigel Pharmaceuticals Inc. (RI2) stock outperform small cap peers2025 Market Overview & Weekly High Potential Stock Alerts - Newser

Dec 03, 2025

Dec 02, 2025

(RIGL) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com

Dec 02, 2025

Is Rigel Pharmaceuticals Inc. (RI2) stock a top dividend aristocrat candidatePortfolio Performance Report & Long-Term Investment Growth Plans - Newser

Dec 02, 2025

Is Rigel Pharmaceuticals Inc. (RI2) stock a buy before new product rolloutWeekly Market Summary & Stock Market Timing Techniques - Newser

Dec 02, 2025

Can Rigel Pharmaceuticals Inc. (RI2) stock ride next bull market cycleTake Profit & Long-Term Capital Growth Strategies - Newser

Dec 02, 2025

Is Rigel Pharmaceuticals Inc. stock a buy for dividend growthMarket Performance Summary & Verified Technical Signals - Newser

Dec 02, 2025

Nov 30, 2025

What analysts say about Rigel Pharmaceuticals Inc RI2 stockVolume Analysis Techniques & Accelerated Financial Growth - earlytimes.in

Nov 30, 2025

Nov 28, 2025

Rigel to Present at the Piper Sandler 37th Annual Healthcare Conference - Eastern Progress

Nov 28, 2025

Is Rigel Pharmaceuticals Inc. stock near bottom after decline2025 Technical Overview & Low Risk Profit Maximizing Plans - moha.gov.vn

Nov 28, 2025

Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? - sharewise.com

Nov 28, 2025

Rigel Pharmaceuticals Inc RI2 Stock Analysis and ForecastSmall Cap Stock Opportunities & Discover Your Financial Freedom Formula - earlytimes.in

Nov 28, 2025

Nov 27, 2025

If EPS Growth Is Important To You, Rigel Pharmaceuticals (NASDAQ:RIGL) Presents An Opportunity - simplywall.st

Nov 27, 2025

Nov 26, 2025